The Budget will continue to be expansionary for financial year 2021, with an expected deficit of $11 billion, or 2.2 per cent of Singapore's gross domestic product.. Read more at straitstimes.com.
The test kits will be used in a new COVID-19 testing lab at Changi Airport.
The Health and Science Authority has approved the use of a deep-throat saliva (DTS) COVID-19 testing kit called RESOLUTE 2.0 by Advanced MedTech Holdings (AMTH).
According to AMTH, the DTS specimen collection is less invasive and more comfortable than the current collection which involves swabs inserted into the back of the nose and throat because DTS collection only requires patients to draw out saliva from deep within their throat and spit into a specimen bottle.
“This makes it easy-to-administer and allows patients to conduct the collection themselves without the supervision of medical professionals, therefore mitigating the risks of potential virus spread as well,” AMTH said.
Share:
APPROVAL ALLOWS
RESOLUTE 2.0 TEST KIT TO BE USED WITH A VARIETY OF TESTING METHODS – INCLUDING DEEP-THROAT SALIVA, OROPHARYNGEAL/MIDDLE TURBINATE AND NASOPHARYNGEAL TEST SWABS
RESOLUTE 2.0 WILL BE USED AT SINGAPORE CHANGI AIRPORT WITH THE NEW ON-SITE ADDITION OF A COVID-19 TESTING LAB IN 2021.
Advanced MedTech Holdings (AMTH), a global medical technology leader headquartered in Singapore, announced today that the RESOLUTE 2.0 test kit has become the first RT-PCR COVID-19 test to be authorised by Singapore s Health Sciences Authority (HSA) for deep-throat saliva (DTS) SARS-CoV-2 testing.
The clinical performance of DTS is supported by clinical studies involving the Diagnostics Development (DxD) Hub hosted by the Agency for Science, Technology and Research (A STAR); Temasek Foundation; Changi General Hospital (CGH); DSO National Laboratories (DSO); and Woodlands Health Campus (WHC). The tests conducted on DTS specimens were able to accurately identify all the known